文献速递儿科与产科急症重症综合管理与镇静镇痛

PICU再入院相关的资源与费用

Resources and Costs Associated With Repeated Admissions to PICUs.
PubMed 文献 · Crit Care Explor · 2021-02-17
一句话结论美国52家儿童医院2年队列中,15.5%的PICU患儿在12个月内再入院并需PICU照护,再入院承担了43.6%的总费用。

该研究利用儿科健康信息系统(Pediatric Health Information System)开展横断面回顾性队列研究,纳入52家三级儿童医院2016年1月1日至2017年12月31日收治的18岁以下PICU患儿。在239,157例指数PICU患儿中,36,970例(15.5%)在指数出院后12个月内再入院并需要PICU照护。所有指数入院和再入院的总费用为173亿美元,其中21.5%(37.1亿美元)发生在涉及PICU照护的再入院期间;在3,459,079个住院日中,20.3%(702,200日)为再入院日(包括需要PICU照护的再入院日)。再入院组慢性复杂疾病比例高于未再入院组(83.9% vs 54.9%;p < 0.001)。与直接出院回家且无家庭医疗照护者相比,出院至专业护理机构的患者再入院几率低18%(OR 0.82 [95% CI, 0.75-0.89];p < 0.001),出院回家并接受家庭医疗照护者再入院几率高43%(OR 1.43 [95% CI, 1.36-1.51];p < 0.001)。作者认为,需要PICU照护的反复入院给美国儿童医院带来了显著的直接医疗费用和资源使用。

要点

  • 239,157例指数PICU患儿中36,970例(15.5%)在12个月内再入院并需PICU照护。
  • 再入院患者承担43.6%的总费用,但仅占指数患者的15.5%和指数住院支出的28%。
  • 再入院组慢性复杂疾病比例83.9%,高于未再入院组的54.9%(p < 0.001)。
  • 出院至专业护理机构者再入院OR 0.82(95% CI 0.75-0.89;p < 0.001),低于直接出院回家且无家庭医疗照护者。
  • 出院回家并接受家庭医疗照护者再入院OR 1.43(95% CI 1.36-1.51;p < 0.001),高于直接出院回家且无家庭医疗照护者。

适用人群与场景

  • 2016年1月1日至2017年12月31日期间入住PICU的18岁以下儿科患者。

研究设计与关键结果

  • 研究设计为使用儿科健康信息系统的横断面回顾性队列研究,纳入52家三级儿童医院。
  • 2年队列共有239,157例指数PICU患者,其中36,970例(15.5%)在指数入院后12个月内再入院并需要PICU照护。
  • 所有指数入院和再入院的总费用为173亿美元,其中21.5%(37.1亿美元)发生在涉及PICU照护的再入院期间。
  • 在3,459,079个住院日中,20.3%(702,200日)为再入院日,包括需要PICU照护的再入院日。
  • 再入院患者中11,703例(30.0%)仅接受PICU照护,对应费用6.62亿美元和110,215个PICU日。
  • 43.6%的总费用与需要再入院的患者相关,但这些患者仅占指数患者的15.5%和指数住院支出的28%。
  • 再入院组指数出院时慢性复杂疾病比例高于未再入院组(83.9% vs 54.9%;p < 0.001)。
  • 与直接出院回家且无家庭医疗照护者相比,出院至专业护理机构者再入院几率低18%(OR 0.82 [95% CI, 0.75-0.89];p < 0.001),出院回家并接受家庭医疗照护者再入院几率高43%(OR 1.43 [95% CI, 1.36-1.51];p < 0.001)。

证据类型、等级与局限

  • 证据类型:横断面回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需要PICU照护的反复入院给美国儿童医院带来了显著的直接医疗费用和资源使用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To determine the costs and hospital resource use from all PICU patients readmitted with a PICU stay within 12 months of hospital index discharge.

DESIGN: Cross-sectional, retrospective cohort study using Pediatric Health Information System.

SETTING: Fifty-two tertiary children's hospitals.

SUBJECTS: Pediatric patients under 18 years old admitted to the PICU from January 1, 2016, to December 31, 2017.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Patient characteristics and costs of care were compared between those with readmission requiring PICU care and those with only a single PICU admission per annum. In this 2-year cohort, there were 239,157 index PICU patients of which 36,970 (15.5%) were readmitted and required PICU care during the 12 months following index admission. The total hospital cost for all index admissions and readmissions was $17.3 billion, of which 21.5% ($3.71 billion) were incurred during a readmission stay involving care in the PICU; of the 3,459,079 hospital days, 20.3% (702,200) were readmission days including those where PICU care was required. Of the readmitted patients, 11,703 (30.0%) received only PICU care, accounting for $662 million in costs and 110,215 PICU days. Although 43.6% of all costs were associated with patients who required readmission, these patients only accounted for 15.5% of the index patients and 28% of index hospitalization expenditures. More patients in the readmitted group had chronic complex conditions at index discharge compared with those not readmitted (83.9% vs 54.9%; p < 0.001). Compared with those discharged directly to home without home healthcare, patients discharged to a skilled nursing facility had 18% lower odds of readmission (odds ratio 0.82 [95% CI, 0.75-0.89]; p < 0.001) and those discharged home with home healthcare had 43% higher odds of readmission (odds ratio, 1.43 [95% CI, 1.36-1.51]; p < 0.001).

CONCLUSIONS: Repeated admissions with PICU care resulted in significant direct medical costs and resource use for U.S. children's hospitals.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Kane JM, Hall M, Cecil C, et al. Resources and Costs Associated With Repeated Admissions to PICUs. Crit Care Explor. 2021. PMID: 33623926. doi:10.1097/CCE.0000000000000347

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。